| P50 | author | Kevin J Anstrom | Q62611770 |
| | Margaret M Redfield | Q98243295 |
| P2093 | author name string | Grace Lin | |
| | Adam D DeVore | |
| | Adrian F Hernandez | |
| | Eric J Velazquez | |
| | Jae K Oh | |
| | Marc J Semigran | |
| | Steven McNulty | |
| | Justin M Vader | |
| | Fawaz Alenezi | |
| | Mads Ersboll | |
| | Gregory Lewis | |
| P2860 | cites work | Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies | Q27000263 |
| | 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q29620107 |
| | Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study | Q33992679 |
| | Exercise physiology in heart failure and preserved ejection fraction | Q34053617 |
| | Normal ranges of left ventricular strain: a meta-analysis | Q34503363 |
| | Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association | Q34505315 |
| | Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction | Q34623775 |
| | 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib | Q34677347 |
| | Phenomapping for novel classification of heart failure with preserved ejection fraction | Q34995857 |
| | Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction | Q35018132 |
| | Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone | Q35921040 |
| | Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota | Q36026805 |
| | Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response | Q36303452 |
| | Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction | Q37156981 |
| | Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial | Q37328507 |
| | Recommendations for the evaluation of left ventricular diastolic function by echocardiography | Q37383745 |
| | The pathophysiology of heart failure with preserved ejection fraction. | Q38222648 |
| | Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography | Q39780430 |
| | Variability of global left ventricular deformation analysis using vendor dependent and independent two-dimensional speckle-tracking software in adults. | Q40063052 |
| | PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design | Q41927225 |
| | Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group | Q43656741 |
| | Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification? | Q44969281 |
| | Clinical significance of pulse pressure in patients with heart failure with preserved left ventricular ejection fraction | Q47640463 |
| | Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. | Q48405753 |
| | Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study | Q48567006 |
| | Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction | Q48725493 |
| | Changes of ventricular and peripheral performance in patients with heart failure and normal ejection fraction: insights from ergometry stress echocardiography. | Q50611098 |
| | Ventricular-vascular interaction in heart failure. | Q51432425 |
| | Doppler tissue analysis of mitral annular velocities: evidence for systolic abnormalities in patients with diastolic heart failure | Q52956031 |
| | Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio | Q57217547 |
| | Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure | Q81685184 |
| P433 | issue | 7 | |
| P921 | main subject | ejection fraction | Q641303 |
| | Heart failure with preserved ejection fraction | Q3799239 |
| | heart failure | Q181754 |
| P304 | page(s) | 893-900 | |
| P577 | publication date | 2017-02-14 | |
| P1433 | published in | European Journal of Heart Failure | Q5017954 |
| P1476 | title | Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial | |
| P478 | volume | 19 | |